CLPS
Colipase
Also known as: COL_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P04118
- Gene
- CLPS
- Ensembl
- ENSG00000137392
- Chromosome
- 6
- Canonical length
- 112 aa
- Protein class
- Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins
- Secretome location
- Secreted to digestive system
OverviewNCBI Gene
The protein encoded by this gene is a cofactor needed by pancreatic lipase for efficient dietary lipid hydrolysis. It binds to the C-terminal, non-catalytic domain of lipase, thereby stabilizing an active conformation and considerably increasing the overall hydrophobic binding site. The gene product allows lipase to anchor noncovalently to the surface of lipid micelles, counteracting the destabilizing influence of intestinal bile salts. This cofactor is only expressed in pancreatic acinar cells, suggesting regulation of expression by tissue-specific elements. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2011]
Canonical amino-acid sequenceUniProt
112 residues, UniProt reviewed canonical sequence.
>P04118|CLPS
1 MEKILILLLV ALSVAYAAPG PRGIIINLEN GELCMNSAQC KSNCCQHSSA LGLARCTSMA
61 SENSECSVKT LYGIYYKCPC ERGLTCEGDK TIVGSITNTN FGICHDAGRS KQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CLPS can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.4
- Highest tissue expression
- 246,874 nTPM
Expression across tissuesHPA
Tissue
- pancreas: 246,874 nTPM
- ovary: 62 nTPM
- heart muscle: 43 nTPM
- salivary gland: 39 nTPM
- duodenum: 38 nTPM
- adipose tissue: 26 nTPM
Single-cell type
- pancreatic acinar cells: 123,993 nCPM
- pancreatic duct cells: 172 nCPM
- neuroendocrine cells: 39 nCPM
- monocytes: 29 nCPM
- mast cells: 21 nCPM
- pancreatic islet cells: 15 nCPM
Immune cell
- neutrophil: 0.5 nTPM
- eosinophil: 0.2 nTPM
- memory CD4 T-cell: 0.2 nTPM
- NK-cell: 0.2 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
Brain region
- cerebral cortex: 5.1 nTPM
- hippocampal formation: 3.9 nTPM
- basal ganglia: 3.3 nTPM
- thalamus: 2.7 nTPM
- white matter: 2.6 nTPM
- medulla oblongata: 2 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.77
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 0.38
- DepMap mean gene effect
- -0.11
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- digestion
- lipid catabolic process
- lipid metabolic process
- response to bacterium
- response to food
- retinoid metabolic process
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Colipase
- Colipase, N-terminal
- Colipase, C-terminal
- Colipase, conserved site
- Colipase, chordates
- Colipase, N-terminal domain
- Colipase, C-terminal domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CLPS as an antibody target. Whether an autoantibody or antibody against CLPS could matter depends on whether native CLPS is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CLPS is annotated as secreted, so native CLPS circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label CLPS as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...